Related Experiment Video
Updated: Jul 10, 2026

13:21
Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
Microarray-based method to analyze methylation status of E-cadherin gene in leukemia
Wenli Zheng1, Yan Wang, Junfeng Luo
1State Key Laboratory of Bioelectronics, Department of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|October 30, 2007
Summary
Aberrant methylation of the E-cadherin gene in leukemia patients was detected using a novel oligonucleotide microarray. This method accurately identifies methylation hotspots, aiding in potential clinical diagnosis.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- Aberrant DNA methylation of tumor suppressor genes is linked to cancer development.
- The E-cadherin gene's methylation status is a potential biomarker for leukemia patients.
Purpose of the Study:
- To develop and validate an oligonucleotide-based microarray for detecting E-cadherin gene methylation in leukemia.
- To identify specific CpG sites within the E-cadherin gene that are frequently methylated in leukemia.
Main Methods:
- Bisulfite modification of DNA followed by PCR amplification.
- Hybridization of amplified DNA to an oligonucleotide-based microarray to detect methylation patterns.
- Validation of microarray results using methylation-specific PCR (MSP).
Main Results:
- All leukemia samples exhibited methylation of the E-cadherin gene at varying levels.
- Specific CpG sites (#16-19 and #20-22) were identified as methylation hotspots.
- The microarray assay quantitatively detected E-cadherin gene methylation changes in leukemia.
Conclusions:
- Oligonucleotide-based microarrays offer a rapid and dependable method for mapping CpG island methylation.
- This microarray technology holds potential for clinical research and diagnostic applications in leukemia.

